# Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer

> **NCT00460551** · PHASE2 · TERMINATED · sponsor: **Genmab** · enrollment: 13 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** Zalutumumab
- **DRUG:** Induction chemotherapy
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00460551
- **Lead sponsor:** Genmab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Due to considerations regarding the appropriate therapeutic regimen for these patients.
- **Last updated:** 2011-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460551, "Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00460551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*